Ignite Creation Date:
2025-12-24 @ 11:48 AM
Ignite Modification Date:
2025-12-30 @ 10:40 AM
Study NCT ID:
NCT01575561
Status:
COMPLETED
Last Update Posted:
2016-08-22
First Post:
2012-03-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Sponsor:
Sumitomo Pharma America, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-06
Start Date Type:
None
Primary Completion Date:
2015-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-07
Completion Date Type:
ACTUAL
First Submit Date:
2012-03-28
First Submit QC Date:
None
Study First Post Date:
2012-04-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-07-11
Results First Submit QC Date:
None
Results First Post Date:
2016-08-22
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-07-11
Last Update Post Date:
2016-08-22
Last Update Post Date Type:
ESTIMATED